Gene Expression Market Report 2026

Gene Expression Market Overview

• Gene Expression market size has reached to $12.67 billion in 2025 • Expected to grow to $22.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.9% • Growth Driver: Elevated Incidence Of Chronic Diseases Fueling The Gene Expression Market • Market Trend: Gene Detection Assay Redefining Gene Expression Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Expression Market?

Gene expression refers to the process by which the information encoded from a gene is used in the production of a functional product, such as a protein. They are used for directing the assembly of a protein molecule and proteins dictate the cell function. The main products of gene expressions are kits and reagents, DNA chips or microarrays, and others. Kits and reagents refer to testing kits that are used to detect certain substances by using them in the field or a lab. The major processes involved are sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation and techniques including RNA exp, promoter analysis, protein exp., and posttranslational modification analysis, used in various applications such as drug discovery and development, clinical diagnostics, biotechnology and microbiology, and others.

What Is The Gene Expression Market Growth Forecast?

The gene expression market size is expected to see rapid growth in the next few years. It will grow to $22.22 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to advancement in RNA sequencing technologies, increasing focus on precision medicine, growth in clinical diagnostics applications, integration of AI in gene expression data analysis, expanding biotechnology industry investments. Major trends in the forecast period include expansion of single-cell gene expression analysis, increasing use of spatial transcriptomics, growing demand for high-throughput PCR platforms, rising adoption of multi-omics integration, standardization of gene expression workflows.

Global Gene Expression Market Segmentation

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products 2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation 3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis 4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications Subsegments: 1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents 2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays 3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

What Is The Driver Of The Gene Expression Market?

The rise in chronic diseases is expected to propel the growth of the gene expression market going forward. Chronic diseases are long-term medical conditions that persist over an extended period, typically three months or more. Gene expression analysis is utilized in chronic diseases to understand the molecular mechanisms underlying the conditions, identify potential biomarkers, and develop targeted therapies. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rise in chronic diseases will drive the growth of the gene expression industry.

Key Players In The Global Gene Expression Market

Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Global Gene Expression Market Trends and Insights

Major companies operating in the gene expression market are focused on developing innovative products, such as gene detection assays, to gain a competitive advantage and increase revenue. A gene detection assay in gene expression pertains to a method for identifying and quantifying the presence of genetic molecules, providing insights into the activity and abundance of specific genes. For instance, in January 2023, Bio-Techne Corporation, a US-based biotech company specializing in research instruments, expanded its Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio by introducing the RNAscope Plus smRNA-RNA detection assay. This new assay allows for the simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers in a single tissue section, offering single-cell and subcellular resolution. Designed to accommodate large studies, the assay is compatible with the Leica Bond Rx platform and is available as a manual assay for convenient use. These therapeutic nucleic acids have the potential to modulate the expression and functionality of specific target genes, facilitating the creation of customized treatments for inherited or acquired diseases that have proven to be resistant to conventional therapies.

What Are Latest Mergers And Acquisitions In The Gene Expression Market?

In January 2023, Qiagen NV, a Germany-based molecular testing solutions company, acquired Verogen for an undisclosed amount. Following this acquisition, Qiagen gains full access to Verogen’s pioneering GEDmatch database and GEDmatch PRO portal, along with exclusive distribution rights for this version of the MiSeq sequencer designed specifically for forensics applications. Verogen is a US-based developer of DNA-based biometric human identification products.

Regional Insights

North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Expression Market?

The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Expression Market Report 2026?

The gene expression market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.